Read more

May 31, 2022
15 min watch
Save

Expert highlights psoriasis treatment, diagnostic presentations from AAD

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this series of videos, April W. Armstrong, MD, MPH, discusses important takeaways from psoriasis sessions at this year’s American Academy of Dermatology Annual Meeting.

Armstrong, associate dean of clinical research and professor of dermatology at Keck School of Medicine at University of Southern California and director of clinical research at the Southern California Clinical and Translational Research Institute, both in Los Angeles, highlighted practice-changing treatments in topical, oral and biologic options.

She also touched on the breadth of diagnostic research at the conference.

“There are a number of exciting developments in terms of diagnostics, in terms of prediction, for psoriasis management,” she said.

Disclosure:

Armstrong reports serving as research investigator and/or scientific advisor to AbbVie, Almirall, Arcutis, ASLAN, Beiersdorf, BI, Bristol Myers Squibb, Dermavant, Dermira, Eli Lilly, EPI, Incyte, Janssen, Leo, ModMed, Nimbus, Novartis, Ortho, Pfizer, Regeneron, Sanofi, Sun and UCB.